Leaps by Bayer co-led a $55m series A round for cancer immunotherapy developer Triumvira Immunologics and is getting two board seats.

The medical research services provider received nearly $43.5m in a round that came seven months after an investment from China Life Private Equity.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Intel Capital came in as a new investor for a round that pushed the genome engineering technology provider's overall funding to $260m.

The healthcare data producer raised $19m from investors including Johnson & Johnson for a round already including Amgen, McKesson, Horizon Health Services, Sanofi and UCB Pharma.

Ci:z Investment led a round also backed by CareNet that advanced the total raised by the spinal disease drug developer to more than $70m.

Salesforce Ventures contributed to an $11.5m round that will fund the addition of more features to Acto's mobile drug information platform.

Cancer and fibrosis therapy developer Forbius has agreed to be acquired by Bristol Myers Squibb nine years after it was spun off by YM BioSciences.

Medical equipment maker Yuanzhi Technology led a $43.5m round that will fund work on BGI-backed YuceBio's TMB biomarker.

Novartis and existing investors GV, Kaiser Permanente Ventures and Roche Venture Fund helped the cancer test developer push its total funding past the $500m mark.